Fwd: INVITATION AND FOR CIRCULATION: Free online training on Preventing the Transfer of Sensitive Biological Research from Pharmaceutical and Related Research Facilities in the Eastern Asian Region to Proliferator States

5 views
Skip to first unread message

Myo Oo

unread,
Nov 21, 2021, 10:21:42 PM11/21/21
to psm...@googlegroups.com
Dear

FYI
Some of the topics will be useful.
May join if you are interested

M




Myo Oo

Clinical Associate Professor
Population Medicine Department
Faculty of Medicine and Health Sciences
University Tunku Abdul Rahman
Sungai Long Campus
Tel: 03-90194722
Website: www.utar.edu.my
Facebook: www.facebook.com/UTARnet
Twitter: www.twitter.com/UTARnet
YouTube: http://www.youtube.com/user/UTARnet




---------- Forwarded message ---------
From: Eddie Kamalzaman <ed...@myohun.com>
Date: Mon, Nov 22, 2021 at 9:13 AM
Subject: INVITATION AND FOR CIRCULATION: Free online training on Preventing the Transfer of Sensitive Biological Research from Pharmaceutical and Related Research Facilities in the Eastern Asian Region to Proliferator States
To: Eddie Kamalzaman <ed...@myohun.com>
Cc: Dr. Latiffah (MyOHUN) <tiffah...@yahoo.com>, Dr Nur Indah Ahmad <nuri...@upm.edu.my>


Dear MyOHUN Members,

Hope everyone had a good weekend and is keeping well. I am writing with regards to a recent opportunity to participate in a free-of-charge online training developed by University of Tennessee in collaboration with the U.S. State Dept and Labyrinth Global Health called "Preventing the Transfer of Sensitive Biological Research from Pharmaceutical and Related Research Facilities in the Eastern Asian Region to Proliferator States."

This will be an online training series of 5-6 modules for public and private pharmaceutical and drug discovery research facilities studying toxins and related biologically active compounds in Indonesia, Malaysia, Philippines, Thailand, and Vietnam. A certificate will be awarded on the completion of the module. The details of each module in the online training are as follows:

Module 1: Understanding Biological Weapons Dual-Use Research Concerns
1. Introduction to Biological Weapons Dual-Use Research Concerns (BW DURC)
2. Introduction to threats from misuse of toxins and related biologically active compounds
3. Risks of doing business with proliferator states
4. Case studies highlighting risks

Module 2:  Potential Misuse of Toxins and Related Biologically Active Compounds
1. Emerging toxins used in pharmaceutical research:
Toxins derived from amphibians and reptiles
Toxins derived from plants
Toxins or marine origin (ex. Saxitoxin)
2. Ricin and Abrin
3. Biologically active compounds used in pharmaceutical research

Module 3: Pharmaceutical and Drug Discovery Research Concerns
1. Physical security
2. Personnel reliability
3. Suspicious Transactions
4. Shipping of materials
5. Disposal of materials
6. Cybersecurity
7. Data and information sharing (conferences, research papers, etc.)
8. Oversight of commercial and research collaboration
9. Research funding sources

Module 4: Assessing and Identifying Risk
1. Identifying suspicious funding sources
2. Identifying suspicious biological supply chains
3. Identifying suspicious transactions
4. Know your customer
Academic
Private sector

Module 5: Best Practices for Reducing Risk
1. Research oversight entities (review boards, etc.)
2. Establishment of research protocols (lab and personnel)
3. Due diligence in purchasing and shipping transactions
4. Best practices in cybersecurity
5. Best practices in data and information sharing
6. Best practices to protect dual-use research collaborations and knowledge
7. Due diligence guidelines for suspicious transactions

Module 6: Strategies for Regional Collaboration
1. Assessing gaps in protocols and procedures
2. Implementing needed enhancements to protocols and procedures
3. Strategies for regional collaboration

Details of Training:
1. Date: To commence in December (Dates to be confirmed). The training is self-paced completion of online training materials.
2. Timeline: To be confirmed
3. Target Participants: Participants should have enough lab proficiency to make such a training worthwhile. This training is designed for people from public and private pharmaceutical and drug discovery research facilities studying toxins and related biologically active compounds in Malaysia. Participants can come from national labs, private industry or universities.  
4. If you wish to be participate in the training, please input your details in the link: https://forms.gle/PPq3xKWog6qPRApx8

IMPORTANT NOTE:
1. Only a maximum of 60 names will be accepted for the training. If more than 60 names are registered by the deadline, the MyOHUN National Coordinating Office (NCO) will select 60 suitable names.
2. The selected names will be passed onto the US State Department where they will be reviewed and approved by the Department. Once approved, a formal invitation will be sent to each individual with specific details on the training.
3. The training will be online and participants will be able to start and finish on their own schedule without direct interaction with the trainers. There will be an assessment at the end of each module. All participants will receive a certificate upon completion.

The deadline to submit your information is 26 NOVEMBER 2021. 

We look forward to your participation. Please feel free to extend this invitation to your colleagues and friends who may be interested. If you have any questions, please do not hesitate to contact me.

Best regards,

Eddie
Raja Khairul Adli (Eddie)
Project Manager
National Coordinating Office (NCO)
Malaysia One Health University Network (MyOHUN)
Faculty of Veterinary Medicine
Universiti Putra Malaysia
43400 Serdang, Selangor
Malaysia

Office: +6 03 9769 3478/3477
HP: +6 014 9688839
Website: www.myohun.com 



DISCLAIMER:
This e-mail and its contents as well as any attachment(s) are solely for the addressee(s) only and may contain privileged and confidential information. Kindly notify the sender and delete this e-mail and all copies in your possession if you are not the intended recipient(s). Any disclosure, copying, distribution, or use of the contents of this information is prohibited.


Reply all
Reply to author
Forward
0 new messages